Mots-clés
Documents disponibles dans cette catégorie (746)
Article
Dermatomyositis is a rare acquired immune-mediated muscle disease characterized by muscle weakness and skin rash. It is classified as one of the idiopathic inflammatory myopathies (IIM). Although all idiopathic inflammatory myopathies share the [...]Publication AFM
Myoinfo, Auteur ; Devaux C, Validateur ; Dupitier E, Validateur ; Eng C, Validateur ; Lagrue E, Validateur ; Leturcq F, Validateur ; Le Voyer AC, Validateur ; Nabarette H, Validateur ; Reveillere C, Validateur ; Urtizberea JA, Validateur ; Groupe d'interet Duchenne/Becker AFM-Telethon, Validateur | AFM-TELETHON | Savoir & Comprendre | 08/2020La dystrophie musculaire de Duchenne est une maladie rare qui se manifeste par une faiblesse musculaire progressive apparaissant dans l’enfance. Ce document a pour but de présenter une information générale sur ce qui peut être fait sur les plan[...]Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]Article
Article
Prasun P | 18/06/2020Clinical characteristics. Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenita[...]Publication AFM
Myoinfo, Auteur ; Bassez G, Validateur ; Furling D, Validateur ; Gourdon G, Validateur ; Loux N, Auteur ; Urtizberea JA, Validateur | AFM-TELETHON | Savoir & Comprendre | 06/2020Steinert disease or myotonic dystrophy type 1 is a rare disease of genetic origin. It affects the muscles, which become weak (dystrophy) and difficult to relax after contraction (myotonia). It also affects other organs (heart and respiratory sys[...]Publication AFM
Myoinfo, Auteur ; Bassez G, Validateur ; Furling D, Validateur ; Gourdon G, Validateur ; Loux N, Validateur ; Urtizberea JA, Validateur | AFM-TELETHON | Savoir & Comprendre | 06/2020Myotonic dystrophy type 2 or PROMM (Proximal Myotonic Myopathy) is a rare disease of genetic origin. It affects the muscles, which become weak (dystrophy) and difficult to relax after contraction (myotonia). It can also affect other organs (hear[...]Publication AFM
Les glycogénoses musculaires sont des maladies musculaires rares d’origine génétique qui se traduisent par une accumulation anormale de glycogène, une forme de réserve énergétique de l'organisme. Elles se manifestent fréquemment par une intolér[...]Article
Article
Highlights: Myotonic dystrophy covers a huge genetic and clinical variability. Review of the current models and literature. Review of molecular methods and interventions. Sharing of existing materials, models, protocols and data. Consensus [...]Article
Zuchner S | 14/05/2020Initial Posting: February 18, 2005; Last Update: May 14, 2020. Clinical characteristics. MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal domi[...]Article
Lefeuvre C ; Schaeffer S ; Carlier RY ; Fournier M ; Chapon F ; Biancalana V ; Nicolas G ; Malfatti E ; Laforet P | 05/2020Article
Carrillo N ; Malicdan MC ; Huizing M | 09/04/2020Initial Posting: March 26, 2004; Last Update: April 9, 2020. Clinical characteristics. GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibial[...]Article
Stunnenberg B ; LoRusso S ; Arnold WD ; Barohn RJ ; Cannon SC ; Fontaine B ; Griggs RC ; Hanna MG ; Matthews E ; Meola G ; Sansone VA ; Trivedi JR ; van Engelen B ; Vicart S ; Statland JM | United States | 04/2020Article
Schoser B | 19/03/2020Initial Posting: September 21, 2006; Last Update: March 19, 2020. Clinical characteristics. Myotonic dystrophy type 2 (DM2) is characterized by myotonia and muscle dysfunction (proximal and axial weakness, myalgia, and stiffness), and less[...]Article
Article
Cortes Vicente E ; Alvarez Velasco R ; Segovia S ; Paradas C ; Casasnovas C ; Guerrero Sola A ; Pardo J ; Ramos Fransi A ; Sevilla T ; Lopez de Munain A ; Gomez MT ; Jerico I ; Gutierrez Gutierrez G ; Pelayo Negro AL ; Martin MA ; Mendoza MD ; Moris G ; Rojas Garcia R ; Diaz-Manera J ; Querol L ; Gallardo E ; Velez B ; Alberti MA ; Galan L ; Garcia Sobrino T ; Martinez-Pineiro A ; Lozano-Veintimilla A ; Fernandez Torron R ; Cano-Abascal A ; Illa I | United States | 03/2020Article
Suarez-Calvet X ; Alonso Perez J ; Castellví I ; Carrasco-Rozas A ; Fernandez-Simon E ; Zamora C ; Martinez-Martinez L ; Alonso-Jimenez A ; Rojas Garcia R ; Turon J ; Querol L ; de Luna N ; Milena-Millan A ; Corominas H ; Castillo D ; Cortes Vicente E ; Illa I ; Gallardo E ; Diaz-Manera J | United States | 03/2020Article
Article
Abrams CK | 20/02/2020Initial Posting: June 18, 1998; Last Update: February 20, 2020. Clinical characteristics. GJB1 disorders are typically characterized by peripheral motor and sensory neuropathy with or without fixed CNS abnormalities and/or acute, self-limite[...]Article
Silva THD ; Anequini IP ; Favero FM ; Voos MC ; Oliveira ASB ; Telles JAR ; Caromano FA | Brazil | 02/2020Article
Garibaldi M ; Fionda L ; Vanoli F ; Leonardi L ; Loreti S ; Bucci E ; Di Pasquale A ; Morino S ; Vizzaccaro E ; Merlonghi G ; Ceccanti M ; Lucchini M ; Mirabella M ; Andreetta F ; Pennisi EM ; Petrucci A ; Salvetti M ; Antonini G | Netherlands | 02/2020Article
Aiko N ; Yamakawa H ; Iwasawa T ; Takemura T ; Okudela K ; Kitamura H ; Hagiwara E ; Ikeda S ; Baba T ; Iso S ; Yamaguchi Y ; Kondo Y ; Kurabayashi T ; Ohashi K ; Sato S ; Ogura T | Netherlands | 02/2020Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]Article
Article
Article
Molenaar JP ; Verhoeven JI ; Rodenburg RJ ; Kamsteeg EJ ; Erasmus CE ; Vicart S ; Behin A ; Bassez G ; Magot A ; Pereon Y ; Brandom BW ; Guglielmi V ; Vattemi G ; Chevessier F ; Mathieu J ; Franques J ; Suetterlin K ; Hanna MG ; Guyant-Marechal L ; Snoeck MM ; Roberts ME ; Kuntzer T ; Fernandez Torron R ; Martínez-Arroyo A ; Seeger J ; Kusters B ; Treves S ; van Engelen BG ; Eymard B ; Voermans NC ; Sternberg D | England | 2020Article
Kaplan FS, Auteur | 01/2020January, 2020 [Revised: Pages 105, 106] // June, 2019 [Revised: Pages 3, 6, 54, 101, 106] From The International Clinical Council on FOP (ICC) & Consultants: Kaplan FS, Al Mukaddam M, Baujat G, Brown M, Cali A, Cho T-J, Crowe C, De Cunto C[...]Article
Tripoli A ; Marasco E ; Cometi L ; De Stefano L ; Marcucci E ; Furini F ; Barsotti S ; Cavagna L | Italy | 01/2020Article
Akesson LS ; Savarirayan R | 2020Clinical characteristics. Fibrodysplasia ossificans progressiva (FOP) is characterized by congenital bilateral hallux valgus malformations and early-onset heterotopic ossification, which may be spontaneous or precipitated by trauma including [...]Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Labrador E ; Weinstein DA | 27/11/2019Initial Posting: April 23, 2009; Last Update: November 27, 2019. Clinical characteristics. Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzy[...]Article
Des mutations récessives dans le gène PYROXD1 ont été récemment décrites chez des patients présentant un tableau de myopathie congénitale ou de dystrophie musculaire des ceintures [1-4]. PYROXD1 (PYRidine nucleotide-disulfide OXidoreductase Doma[...]Article
Article
Gunther R, Auteur ; Wurster CD ; Cordts I ; Koch JC ; Kamm C ; Petzold D ; Aust E ; Deschauer M ; Lingor P ; Ludolph AC ; Hermann A | Switzerland | 11/2019Article
Article
Article
Bjelica B, Auteur ; Peric S ; Basta I ; Bozovic I ; Kacar A ; Marjanovic A ; Ivanovic V ; Brankovic M ; Jankovic M ; Novakovic I ; Rakocevic Stojanovic V | Italy | 11/2019Article
Annals of neurology POPDC3 Gene Variants Associate with a New Form of Limb Girdle Muscular Dystrophy
Vissing J, Auteur ; Johnson K ; Topf A ; Nafissi S ; Diaz-Manera J ; French VM ; Schindler RF ; Sarathchandra P ; Lokken N ; Rinne S ; Freund M ; Decher N ; Müller T ; Duno M ; Krag T ; Brand T ; Straub V | United States | 10/2019Article
Pinal Fernandez I, Auteur ; Mecoli CA ; Casal-Dominguez M ; Pak K ; Hosono Y ; Huapaya J ; Huang W ; Albayda J ; Tiniakou E ; Paik JJ ; Johnson C ; Danoff SK ; Corse AM ; Christopher Stine L ; Mammen AL | United States | 10/2019Article
Kimonis V | 12/09/2019Initial Posting: May 25, 2007; Last Update: September 12, 2019. Clinical characteristics. Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal [...]Article
Peric S ; Stevanovic J ; Johnson K ; Kosac A ; Peric M ; Brankovic M ; Marjanovic A ; Jankovic M ; Banko B ; Milenkovic S ; Durdic M ; Bozovic I ; Glumac JN ; Lavrnic D ; Maksimovic R ; Milic-Rasic V ; Rakocevic-Stojanovic V | Italy | 09/2019Article
Ngiwsara L, Auteur ; Wattanasirichaigoon D ; Tim-Aroon T ; Rojnueangnit K ; Noojaroen S ; Khongkraparn A ; Sawangareetrakul P ; Ketudat-Cairns JR ; Charoenwattanasatien R ; Champattanachai V ; Kuptanon C ; Pangkanon S ; Svasti J | England | 09/2019Article
Article
Penttila S ; Vihola A ; Palmio J ; Udd B | 22/08/2019Initial Posting: November 29, 2012; Last Update: August 22, 2019. Clinical characteristics. The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal m[...]Article
Bonne G ; Leturcq F ; Ben Yaou R | 15/08/2019Initial Posting: September 29, 2004; Last Update: August 15, 2019. Clinical characteristics. Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progr[...]Article
Magoulas PL ; El-Hattab AW | 01/08/2019Initial Posting: January 3, 2013; Last Update: August 1, 2019. Clinical characteristics. The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ag[...]Article
Saito K | 03/07/2019Initial Posting: January 26, 2006; Last Update: July 3, 2019. Clinical characteristics. Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that[...]Article
Initial Posting: June 20, 2019. Clinical characteristics. STAC3 disorder is characterized by congenital myopathy, musculoskeletal involvement of the trunk and extremities, feeding difficulties, and delayed motor milestones. Most affected ind[...]Article
Article
Hackman P ; Savarese M ; Carmignac V ; Udd B ; Salih MA | 11/04/2019Initial Posting: January 12, 2012; Last Update: April 11, 2019. Clinical characteristics. Salih myopathy is characterized by muscle weakness (manifest during the neonatal period or in early infancy) and delayed motor development; children ac[...]Article
Erratum in : Corrigendum to "Recently Identified Congenital Myopathies" [Semin Pediatr Neurol 29 (2019) 83-90].Article
Lagrue E ; Dogan C ; De Antonio M ; Audic F ; Bach N ; Barnerias C ; Bellance R ; Cances C ; Chabrol B ; Cuisset JM ; Desguerre I ; Durigneux J ; Espil C ; Fradin M ; Heron D ; Isapof A ; Jacquin-Piques A ; Journel H ; Laroche-Raynaud C ; Laugel V ; Magot A ; Manel V ; Mayer M ; Pereon Y ; Perrier-Boeswillald J ; Peudenier S ; Quijano Roy S ; Ragot-Mandry S ; Richelme C ; Rivier F ; Sabouraud P ; Sarret C ; Testard H ; Vanhulle C ; Walther Louvier U ; Gherardi R ; Hamroun D ; Bassez G | 19/02/2019Article
Wieser T | 03/01/2019Initial Posting: August 27, 2004; Last Revision: January 3, 2019. Clinical characteristics. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal n[...]Article
Article
Okur D ; Daimaguler HS ; Danyeli AE ; Tekgul H ; Wang H ; Wunderlich G ; Cirak S ; Yis U | Turkey | 2019Article
El-Hattab AW ; Almannai M ; Scaglia F | 29/11/2018Initial Posting: February 27, 2001; Last Update: November 29, 2018. Clinical characteristics. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with protean manifestations. The vast [...]Article
Herbert M ; Goldstein JL ; Rehder C ; Austin S ; Kishnani PS ; Bali DS | 01/11/2018Initial Posting: May 31, 2011; Last Update: November 1, 2018. Clinical characteristics. Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, whi[...]Article
Article
Dowling JJ ; Lawlor MW ; Das S | 23/08/2018Initial Posting: February 25, 2002; Last Update: August 23, 2018. Clinical characteristics. X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. [...]Article
Wolfe L ; Jethva R ; Oglesbee D ; Vockley J | 09/08/2018Initial Posting: September 22, 2011; Last Update: August 9, 2018. Clinical characteristics. Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through newborn screening programs have remained well, and asympto[...]Article
Weber F ; Lehmann-Horn F | 26/07/2018Initial Posting: April 30, 2002; Last Update: July 26, 2018. Clinical characteristics. Hypokalemic periodic paralysis (hypoPP) is a condition in which affected individuals may experience paralytic episodes with concomitant hypokalemia (ser[...]Article
Wang J ; El-Hattab AW | 26/07/2018Initial Posting: December 6, 2012; Last Update: July 26, 2018. Clinical characteristics. TK2-related mitochondrial DNA (mtDNA) maintenance defect is a phenotypic continuum that ranges from severe to mild. To date, approximately 107 individua[...]Article
Goselink RJM, Auteur ; van Kernebeek CR ; Mul K ; Lemmers RJLF ; van der Maarel SM ; Brouwer OF ; Voermans N ; Padberg GW ; Erasmus CE ; van Engelen BGM | 03/05/2018Comment in: Genotype-phenotype correlation: The ultimate challenge in facioscapolohumeral muscular dystrophy. [Eur J Paediatr Neurol. 2018]Article
Ivanov I, Auteur ; Atkinson D ; Litvinenko I ; Angelova L ; Andonova S ; Mumdjiev H ; Pacheva I ; Panova M ; Yordanova R ; Belovejdov V ; Petrova A ; Bosheva M ; Shmilev T ; Savov A ; Jordanova A | 03/04/2018Article
Garone C, Auteur ; Taylor RW ; Nascimento A ; Poulton J ; Fratter C ; Dominguez Gonzalez C ; Evans JC ; Loos M ; Isohanni P ; Suomalainen A ; Ram D ; Hughes MI ; McFarland R ; Barca E ; Lopez Gomez C ; Jayawant S ; Thomas ND ; Manzur AY ; Kleinsteuber K ; Martin MA ; Kerr T ; Gorman GS ; Sommerville EW ; Chinnery PF ; Hofer M ; Karch C ; Ralph J ; Camara Y ; Madruga-Garrido M ; Dominguez-Carral J ; Ortez C ; Emperador S ; Montoya J ; Chakrapani A ; Kriger JF ; Schoenaker R ; Levin B ; Thompson JLP ; Long Y ; Rahman S ; Donati MA ; DiMauro S ; Hirano M | 30/03/2018Article
DA Dyment ; Bennett SAL ; Medin JA ; Levade T | 29/03/2018Initial Posting: March 29, 2018. Clinical characteristics. The spectrum of ASAH1-related disorders ranges from Farber disease (FD) to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). Classic FD is characterized b[...]Article
Mori Yoshimura M, Auteur ; Mitsuhashi S ; Nakamura H ; Komaki H ; Goto K ; Yonemoto N ; Takeuchi F ; Hayashi YK ; Murata M ; Takahashi Y ; Nishino I ; Takeda S ; Kimura E | 26/03/2018Article
Article
Szymaiska E, Auteur ; Szymaiska S ; Truszkowska G ; Ciara E ; Pronicki M ; Shin YS ; Podskarbi T ; Kepka A ; spiewak M ; Ptoski R ; Bilinska ZT ; Rokicki D | 2018Article
Article
Todd JJ, Auteur ; Razaqyar MS ; Witherspoon JW ; Lawal TA ; Mankodi A ; Chrismer IC ; Allen C ; Meyer MD ; Kuo A ; Shelton MS ; Amburgey K ; Niyazov D ; Fequiere P ; Bonnemann CG ; Dowling JJ ; Meilleur KG | 2018Article